Acute coronary syndromes: pathology, diagnosis, genetics, prevention, and treatment.
暂无分享,去创建一个
[1] M. Pfeffer,et al. A sensitive cardiac troponin T assay in stable coronary artery disease. , 2009, The New England journal of medicine.
[2] A. Íñiguez,et al. Effect of Early Metoprolol on Infarct Size in ST-Segment–Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: The Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) Trial , 2013, Circulation.
[3] J. Deckers. Classification of myocardial infarction and unstable angina: a re-assessment. , 2013, International journal of cardiology.
[4] K. Fox,et al. Risk stratification in non-ST-segment elevation acute coronary syndromes: troponin alone is not enough. , 2009, The American journal of medicine.
[5] V. Fuster,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.
[6] C. Mueller. Biomarkers and acute coronary syndromes: an update. , 2014, European heart journal.
[7] J. Narula,et al. Year in Review: Advances in Understanding of Plaque Composition and Treatment Options , 2014 .
[8] Jeroen J. Bax,et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation , 2012 .
[9] H. Katus,et al. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. , 2010, Clinical chemistry.
[10] H. Bøtker,et al. Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention. , 2014, European heart journal.
[11] L. Berkman,et al. Genetic susceptibility to death from coronary heart disease in a study of twins. , 1994, The New England journal of medicine.
[12] J. Narula,et al. Advances in the understanding of plaque composition and treatment options: year in review. , 2014, Journal of the American College of Cardiology.
[13] E. Antman,et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. , 2000, JAMA.
[14] V. Fuster,et al. From Treating Complex Coronary Artery Disease to Promoting Cardiovascular Health: Therapeutic Transitions and Challenges, 2010–2020 , 2011, Clinical pharmacology and therapeutics.
[15] S. Kurz,et al. Introduction of high-sensitivity troponin assays: impact on myocardial infarction incidence and prognosis. , 2012, The American journal of medicine.
[16] Pierre Croisille,et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. , 2008, The New England journal of medicine.
[17] C. Kramer. Avoiding the imminent plague of troponinitis: the need for reference limits for high-sensitivity cardiac troponin T. , 2014, Journal of the American College of Cardiology.
[18] Jeroen J. Bax,et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.
[19] D. Fitzgerald,et al. Ticlopidine and clopidogrel. , 1999, Circulation.
[20] C. Hamm,et al. Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome. , 2011, American heart journal.
[21] V. Fuster,et al. Coronary artery disease: pathogenesis and acute coronary syndromes. , 2001, The Mount Sinai journal of medicine, New York.
[22] Akiko Maehara,et al. A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.
[23] Fred S Apple,et al. Third universal definition of myocardial infarction , 2012 .
[24] L. Neyses,et al. Kardiologische Aspekte der präoperativen Risikostratifizierung , 2011 .
[25] V. Fuster,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). , 1992, The New England journal of medicine.
[26] Bernadette A. Thomas,et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.
[27] K. Eagle,et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) , 2006, BMJ : British Medical Journal.
[28] S. Jha,et al. Beta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation. , 2011, Journal of the American College of Cardiology.
[29] J. Spertus,et al. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, Am , 2012, Journal of the American College of Cardiology.